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INTRODUCTION
Tracheal transplantation remains a challenge for General
Thoracic Surgery.1 A large number of surgical techniques
and implantable devices has been tested with poor results.1,2
In spite of that, some recent findings on tracheal revascular-
ization and graft epithelial replacement have renewed the
interest on tracheal transplantation, with special attention to
graft bioengineering.2-5 However, in order to succeed in
tracheal transplantation, the effects of tracheal ischemic
injury secondary to harvesting need to be better understood.
Functional preservation of solid organs is usually
achieved by the use of intravascular preservation solutions.6
However, because of the particular segmental pattern of the
tracheal vascularization, with no major tracheal vessels,7
intravascular administration of preservation solutions into
tracheal grafts is technically complex,8 and far from being
useful in a clinical scenario. The trachea is composed of thin
cell layers and maintains an open lumen after harvesting.
Based on those anatomical characteristics, we hypothesized
if a topically-applied preservation solution could penetrate
into tracheal layers and maintain mucociliary function of
tracheal grafts submitted to either warm or cold ischemia.
Our objectives were: 1) to evaluate if topically-applied
LPD-glucose, a solution largely used for lung preservation,
could ameliorate the effects of warm (room temperature)
ischemia on tracheal mucociliary clearance; and 2) to
evaluate if topically-applied LPD-glucose could ameliorate
the effects of cold ischemia on tracheal mucociliary
clearance.
METHODS AND MATERIALS
This research was approved by the Ethical Committee of
our Institution. All animals were treated in agreement with
the Brazilian regulation for the use of animals for scientific
research.
In order to address the first objective, we obtained 31
tracheal segments from 16 Wistar male rats (weight,
300¡50g). The rats were anesthetized with intraperitoneal
pentobarbital (50mg/kg), and euthanized by exsanguina-
tion. A median cervicosternotomy was performed, followed
by tracheal harvesting. The trachea was sectioned at the
middle length providing two tracheal segments from each
rat. Right after harvesting, the tracheal segments were
submerged in saline solution or LPD-glucose (Vitrolife AB,
Gothenburg, Sweden), and stored at room temperature
during the established ischemic time. The tracheal segments
were allocated to one of six groups as follows: Group 1A
(Saline solution, 6h of ischemia); Group 1B (Saline solution,
16h of ischemia); Group 1C (Saline solution, 24h of
ischemia); Group 2A (LPD-glucose, 6h of ischemia); Group
2B (LPD-glucose, 16h of ischemia); Group 2C (LPD-glucose,
24h of ischemia).
In order to address the second objective, we obtained 34
tracheal segments from 17 Wistar male rats (weight,
300¡50g). The anesthetic procedure, the surgical technique,
and the tracheal harvesting were the same as described
above. Right after harvesting, the tracheal segments were
submerged in saline solution or LPD-glucose, and stored at
4 C˚ during the established ischemic time. The tracheal
segments were allocated to one of six groups as follows:
Group 3A (Saline solution, 6h of ischemia); Group 3B (Saline
solution, 16h of ischemia); Group 3C (Saline solution, 24h of
ischemia); Group 4A (LPD-glucose, 6h of ischemia); Group
4B (LPD-glucose, 16h of ischemia); Group 4C (LPD-glucose,
24h of ischemia).
In order to achieve a baseline measure, 05 tracheal
segments were obtained from 03 Wistar male rats as
described above, and analyzed just after harvesting
(Control Group).
Mucociliary clearance analysis
The mucociliary clearance was analyzed by the ciliary
beating frequency (CBF) and the in situ mucociliary
transport (MT), as described previously.9-12 Briefly, after
the established ischemic period, the ventral wall of each
tracheal segment was opened to expose the epithelium. The
tracheal segment was placed under a light microscope
(Olympus BX50, Tokyo, Japan), that was connected to a
video camera (Sony Triniton 3CCD, Tokyo, Japan), with a
100x magnification. MT was measured by timing the
movement of mucous particles across the tracheal surface
with the aid of a reticulated eyepiece. MT was considered
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present when there was any measurable transportation, and
was considered absent when there was no measurable
transportation.
Afterwards, under the same microscope, a stroboscope
(Machine Vision Strobe, Cedar-Hurst, USA) was placed in
front of the tracheal segment, and CBF was measured by
synchronization between the cilia movement and the
stroboscope flashlight. CBF was considered present when
there was any measurable ciliary beating, and was
considered absent when there was no measurable ciliary
beating. When present, the CBF was expressed in Hertz
(Hz).
Data presentation and Statistical analysis
Data was presented as mean ¡ standard deviation for
numerical variables. ANOVA with Bonferroni post-test was
used for numerical variables when appropriate. Fisher’s
exact test was used for categorical variables when appro-
priate. Statistical significance was considered when p,0.05.
RESULTS
Groups submitted to warm ischemia
When the tracheal segments were submitted to warm
ischemia, the mucociliary clearance was severely impaired,
chiefly in the groups with more than 6h of ischemia. Two of
three tracheal segments in Group 1A, and three of four
tracheal segments in Group 2A had present CBF. However,
the CBF was absent in all tracheal segments in Groups 1B,
1C, 2B and 2C. The MT was absent in all groups (Group 1A
to 2C), but for one tracheal segment in Group 2B.
Groups submitted to cold ischemia
The CBF values (in Hz) found 10.94 ¡1.13 in Group 3A;
12.70 ¡3.10 in Group 3B; 9.32 ¡4.46 in Group 3C; 8.90
¡6.18 in Group 4A; 14.38 ¡1.80 in Group 4B; and 11.59
¡1.89 in Group 4C. The CBF could be measured in all but
two segments (Group 4A and Group 3C, each). There was
no statistical difference among Groups 3A to 4C (p= 0.11).
Even when the Control Group (CBF= 15.21 ¡4.39) was
included in the analysis, there was no significant difference
on CBF among the groups (p= 0.054).
The MT was present in 26% of tracheal segments
submerged in saline solution (Groups 3A, 3B, and 3C),
and in 46% of tracheal segments submerged in LPD-glucose
(Groups 4A, 4B, and 4C). However, this difference was not
statistically significant (p = 0.28).
DISCUSSION
Mucociliary clearance is the primary defense mechanism
of the respiratory system.13 The trachea has an essential role
in mucociliary clearance by impelling the mucus from the
lower to the upper airways to be expelled by cough or
swallowed.14 Therefore, the maintenance of tracheal muco-
ciliary clearance seems to be an important aim for tracheal
graft preservation.
Based on tracheal anatomy, we proposed a novel
approach to tracheal graft preservation. Because of the
semi-rigid tracheal structure,7 the tracheal lumen remains
open after harvesting. This could allow continuous contact
of the preservation solution with the respiratory epithelium
during the ischemic period, what could enhance epithelium
preservation. Preservation solution could also penetrate into
the other tracheal layers through the highly water-perme-
able respiratory epithelium.15
Because of the simpler anatomic and physiologic struc-
ture of the trachea, its metabolic requirements are supposed
to be lower than those of other solid organs.16 This could
allow at least a short period of warm ischemia after tracheal
harvesting. However, based on the showed data, warm
ischemia cannot be allowed after tracheal harvesting, even
during short periods.
When the tracheal segments where stored at 4 C˚, the CBF
could be measured on almost all of them. The ischemic time
up to 24h at 4 C˚ did not seem to severely impair the tracheal
CBF in our study. Interestingly, even when the Control
Group is included in the analysis, the difference among
groups did not reach statistical significance. Although this
finding might be related to the small sample size of the
groups, it suggests that tracheal mucociliary clearance could
benefit from cold storage. Besides that, MT was present in
several tracheal segments after cold storage. Although MT
was absent in the majority of tracheal grafts submitted to
cold ischemia, more tracheal segments submerged in LPD-
glucose had present MT compared to those submerged to
saline solution. However, the difference did not reach
statistical significance. Thereafter, the major factor impli-
cated on tracheal preservation, as assessed by mucociliary
clearance, seems to be the storage temperature, and not the
preservation solution.
However, the mucociliary clearance is directly affected by
the physical properties of the mucus. Topically-applied
solutions, including saline solution, can alter the rheological
properties of mucus and impair the mucociliary clear-
ance.17,18 So, the not significant difference on mucociliary
clearance of the tracheal segments submerged to LPD-
glucose or saline solution could be related solely to the
modification of rheological properties of the mucus.
Our study has some limitations. We did not perform
histological evaluation of the tracheal segments. Therefore,
in spite of the better mucociliary function of tracheal
segments submitted to cold ischemia, there are no data
about the cellular integrity of some important tracheal
tissues, namely respiratory epithelium and cartilage. Other
limitation is the small sample size in some groups, which
could lead to statistical misinterpretation.
CONCLUSIONS
We conclude that topically applied LPD-glucose did not
ameliorate the effects of both warm and cold ischemia on
tracheal mucociliary clearance in rats. However, studies
with larger sample size, including evaluations about the
effects of preservation solutions on cellular morphology and
mucous rheology are necessary in order to discard or not
the use of topically-applied preservation solutions for
tracheal preservation.
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